Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors
US10501459B2 · kind B2 · utility
0Cited by
5References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2016 |
| Grant date | Dec 10, 2019 |
| Priority date | — |
| Expiry date | Oct 20, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This application relates to substituted imidazopyridines, compositions comprising them and their uses in the treatment of diseases and conditions in which inhibition of a bromodomain is indicated. For example, the application relates to substituted imidazopyridines of Formula I and to their use as bromodomain inhibitors.The present application is also related to the treatment or prevention of proliferative disorders, auto-immune disorders, inflammatory disorders, dermal disorders, and neoplasms, including tumors and/or cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.